Showing results (101-110 of 146) with videos related to

Sort By:
Pageof 15
Oncogene|January 25, 2003
Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasisDaoyan Wei, Xiangdong Le, Leizhen Zheng, et al.
Translational Oncology|May 11, 2019
Overexpressed ABCB1 Induces Olaparib-Taxane Cross-Resistance in Advanced Prostate CancerAlan P Lombard, Chengfei Liu, Cameron M Armstrong, et al.
Molecular and Cellular Biology|May 31, 2012
Histone methyltransferase NSD2/MMSET mediates constitutive NF-κB signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loopPing Yang, Linlang Guo, Zhijian J Duan, et al.
Molecular Cancer Therapeutics|May 21, 2020
Cross-Resistance Among Next-Generation Antiandrogen Drugs Through the AKR1C3/AR-V7 Axis in Advanced Prostate CancerJinge Zhao, Shu Ning, Wei Lou, et al.
Urologic Oncology|October 15, 2018
What kind of patients with castration-naïve prostate cancer can benefit from upfront docetaxel and abiraterone: A systematic review and a network meta-analysisGuangxi Sun, Xingming Zhang, Junru Chen, et al.
Molecular Cancer Therapeutics|July 17, 2019
AKR1C3 Promotes AR-V7 Protein Stabilization and Confers Resistance to AR-Targeted Therapies in Advanced Prostate CancerChengfei Liu, Joy C Yang, Cameron M Armstrong, et al.
Molecular Cancer Therapeutics|May 14, 2017
Niclosamide and Bicalutamide Combination Treatment Overcomes Enzalutamide- and Bicalutamide-Resistant Prostate CancerChengfei Liu, Cameron M Armstrong, Wei Lou, et al.
Cancers|June 26, 2025
Steroid Sulfatase Regulates Metabolic Reprogramming in Advanced Prostate CancerMasuda Sharifi, Cameron M Armstrong, Shu Ning, et al.
Iscience|February 8, 2024
IGFBP3 promotes resistance to Olaparib via modulating EGFR signaling in advanced prostate cancerAmy R Leslie, Shu Ning, Cameron M Armstrong, et al.
Pharmacological Research|February 11, 2023
Allosteric inhibition of HSP70 in collaboration with STUB1 augments enzalutamide efficacy in antiandrogen resistant prostate tumor and patient-derived modelsPengfei Xu, Joy C Yang, Shu Ning, et al.
Pageof 15